	Concurrent Adenoid Cystic/Basal Cell Carcinoma and Acinar Adenocarcinoma of the Prostate: Comprehensive Molecular Analysis of Both Tumor Component. Int J Surg Pathol Pivovarcikova K, Alaghehbandan R, Bradova M, Ptakova N, Martinek P, Vanecek T, Michal M, Fiala O, Hora M, Ondic O. PMID: 42606337 [PubMed - as supplied by publisher]
	Enzalutamide-Induced Host Metabolic Reprogramming Is Associated with Treatment Outcomes in Patients with Castration-Resistant Prostate Cancer: A Hypothesis-Generating Study. Clin Pharmacol Ther Corona G, Visentin M, Samodelov SL, Maines F, Caffo O, Miolo G. PMID: 42606154 [PubMed - as supplied by publisher]
	Association of Postoperative Antidepressant and Anxiolytic Exposure With Overall Survival Following Radical Cystectomy for Bladder Cancer. Psychooncology Huang CS, Tung KH, Wu YS, Yu CP, Yu DS, Yang MH, Lee YE, Ho JY. PMID: 42606027 [PubMed - indexed for MEDLINE]
	Artificial intelligence for predicting BCG response in non-muscle-invasive bladder cancer: a systematic review. BJU Int Cella L, Contieri R, Paciotti M, Fasulo V, Uleri A, Avolio PP, Mertens LS, Pradere B, Perdonà S, Saita A, Lazzeri M, Casale P, Lughezzani G, Hurle R, Buffi NM. PMID: 42605566 [PubMed - as supplied by publisher]
	Editorial Comment to Real-World Outcomes and Prognostic Factors of Immune Checkpoint Inhibitor Rechallenge for Metastatic Renal Cell Carcinoma: A Multicenter Study. Int J Urol Okumi M. PMID: 42605512 [PubMed - in process]
	When to Intervene in Renal Masses: Integrating Tumor Biology, Patient Fitness, and Competing Mortality Into Clinical Decision-Making. Cureus Buali HF, Albenjasim K, Al Shaibani A, Aljeeran N, Rafie M. PMID: 42605385 [PubMed]
	Advances in NIR-II Fluorescence Laparoscopy for Precision Diagnosis and Theranostics of Urological Oncology. Int J Nanomedicine Liu Q, Li S, Xu M, Rong S, Wei Y, Li J, Jia F, Li S, Zhang H, He J, Liu C, Yang X. PMID: 42605362 [PubMed - indexed for MEDLINE]
	Flexible intervention workflow for MRI guided robotic prostate seed brachytherapy. J Appl Clin Med Phys Aumueller P, Dannert ML, Polednik M, Giordano FA, Fleckenstein J, Clausen S. PMID: 42605022 [PubMed - indexed for MEDLINE]
	Salvage therapies for local recurrence of renal cell carcinoma: a systematic review and meta-analysis. World J Urol Suleja A, Alfarhan AR, Miszczyk M, Campi R, Hamdhah HA, Amparore D, Francolini G, Roessler N, Miyajima K, Inoue S, Lübbersmeyer F, Alhazeem AA, Rajwa P, Bex A, Volpe A, Ost P, Shariat SF. PMID: 42604476 [PubMed - indexed for MEDLINE]
	Primary Chondroblastic Osteosarcoma of the Kidney: A Case Report and Review of Literature. Arch Iran Med Bedir R, Yazar S. PMID: 42604430 [PubMed - indexed for MEDLINE]
	Impact of Photodynamic Diagnosis on Immune Cell Infiltration in BCG-treated Non-muscle-invasive Bladder Cancer. Eur Urol Open Sci Andreasen TG, Strandgaard T, Divita TJ, Young-Halvorsen K, Neijber A, Dyrskjøt L. PMID: 42604152 [PubMed]
	Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts. Int J Urol Ichiyama T, Narita T, Sato H, Sekine Y, Shinohara M, Kawashima Y, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S. PMID: 42603090 [PubMed - indexed for MEDLINE]
	Perioperative Outcomes of Salvage Radical Prostatectomy After Radiation Therapy: A Nationwide Analysis Using the National Clinical Database of Japan. Int J Urol Fujita K, Makita A, Ishii D, Yamamoto H, Yasui T, Kikuchi E. PMID: 42603088 [PubMed - indexed for MEDLINE]
	Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis. Int J Urol Iwamoto H, Izumi K, Hori T, Inaba T, Nakagawa R, Kamijima T, Makino T, Naito R, Yaegashi H, Shigehara K, Nohara T, Yamada Y, Shimomura T, Onishi K, Mizokami A. PMID: 42603083 [PubMed - indexed for MEDLINE]
	Decoding the role of exosomes in bladder cancer: focusing on tumor progression and immune microenvironment modulation. Front Oncol Wang X, Li Z, Zhang B. PMID: 42602585 [PubMed]
	Bladder mucosal apoptosis index and quality of life after adjuvant intravesical BCG therapy for non-muscle-invasive bladder cancer: a retrospective propensity-score-matched study. Front Oncol Zhu H, Tan S, Liu X. PMID: 42601890 [PubMed]
	Induced proximity-based therapeutics for advanced prostate cancer. NPJ Drug Discov Ching J, Chau CH, Figg WD. PMID: 42601416 [PubMed]
	Application Study of Clinical Features Combined With Ultrasound-based Radiomics Nomogram For Grading Diagnosis of Bladder Urothelial Carcinoma. Acad Radiol Zhang HP, Fu F, Fan XQ, Li ZY, Zhu YF, Zheng WT, Zhuang JJ, Chen YF, Lian GT, Lin XH, Ye Q. PMID: 42601302 [PubMed - as supplied by publisher]
	Re: Siva S, Ali M, Hardcastle N, et al. Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-Year Outcomes from a Pooled Analysis of the FASTRACK Trials. Lancet Oncol. In press. https://doi.org/10.1016/S1470-2045(26)00170-1 and re: Siva S, Pryor D, Martin J, et al. Long-term Outcomes of Stereotactic Ablative Body Radiotherapy for Primary Kidney Cancer (TROG 15.03 FASTRACK II): A Multicentre, Non-randomised, Phase 2 Study. Lancet Oncol. In press. https://doi.org/10.1016/S1470-2045(26)00091-4. Eur Urol Capitanio U, Bex A, Stewart GD, Larcher A, Montorsi F. PMID: 42601237 [PubMed - as supplied by publisher]
	Time toxicity in patients receiving brachytherapy and hormonal therapy for recurrent prostate cancer: a cohort study. BMJ Support Palliat Care Chow R, Bayrakdarian S, Zimmermann C, Richards GC, Heneghan C, Leigh J, Chung H. PMID: 42601182 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180759

Page 1 of 9038



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy